osteoblastic


Also found in: Dictionary, Thesaurus, Encyclopedia.

os·te·o·blas·tic

(os'tē-ō-blas'tik),
Relating to the osteoblasts; describes any region of increased radiographic bone density, in particular, metastases that stimulate osteoblastic activity.

os·te·o·blas·tic

(os'tē-ō-blas'tik)
Relating to the osteoblasts; describes any region of increased radiographic bone density, in particular, metastases that stimulate osteoblastic activity.

os·te·o·blas·tic

(os'tē-ō-blas'tik)
Relating to osteoblasts; describes any region of increased radiographic bone density.

osteoblastic

emanating from or pertaining to an osteoblast.
References in periodicals archive ?
To analyze the effects of the recombinant pearlin on cell proliferation and osteoblastic differentiation, MRC-5 fibroblast and MC3T3-E1 preosteo-blast cells showed to respond to differentiating factors that promote osteoblastic phenotype (Almeida et al.
sup][78] Finally, adiponectin, an adipocyte derivative hormone, modulates osteoblastic differentiation through its receptors pathway 1/p38.
Osteoblastic and osteoclastic cells were cultured according to our recent work (Ma et al.
We found low Pb-responsive expression of its gene, Sost, in MC3T3-E1 osteoblastic cells relative to Runx2 and [beta]-catenin expression (based on normalized CT values).
Since fluoride acts as an anabolic agent for bone cells and that its osteogenic properties are mediated primarily by an increase in osteoblastic proliferation, as well as most of the fluoride is deposited in actively mineralizing areas of bone cartilage, and the mitogenic action of fluoride and genotoxicity action (ability of fluoride to induce chromosomal aberrations) was subsequently confirmed by a number of laboratories on bone cells of various species, including humans.
Keywords: Osteoid osteoma, Osteoblastic tumour, Acetabulum.
2] were released and diffused to reach the osteoblast and stimulated the proliferation and differentiation of osteoblastic cells and inhibited the activity and differentiation of osteoclasts, thereby enhancing matrix deposition and, ultimately, new bone formation as shown in figure 3.
The new trial will compare the effectiveness of the osteoblastic (bone-forming) product Preob to other treatments, and will run until late 2017.
OPG is a decoy receptor produced by osteoblastic cells which compete with RANK for RANKL binding.
Osteoblastic metastases occur in the older age group, are generally larger in size and do not have such a uniformly symmetric distribution.
3,6,7) JOF are characterized by fibrocellular stroma of spindle- or stellate-shaped cells with bony trabeculae, with or without osteoblastic rimming, and lacking cementicles or a formal capsule.